The Lancet: May 01, 2009

The Lancet in conversation with - A podcast by The Lancet Group - Fridays

Categories:

Education

Robert Pirker discusses the research article about the human monoclonal antibody cetuximab in the treatment of lung cancer.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv